Skip to content
Screener

Schering-Plough SGP Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

EyePoint, Inc. logo
EyePoint, Inc.EYPT
$9.37M+58.9%
Sight Sciences, Inc. logo
Sight Sciences, Inc.SGHT
$580K+50.3%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
AbbVie logo
AbbVieABBV
Bausch + Lomb logo
Bausch + LombBLCO
Bausch Health Companies logo
Bausch Health CompaniesBHC

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M
Total equity$250.1M+463%
Total assets$258.4M

Cash flow

See full
Operating cash flow-$13.5M-65.2%
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$846.2M+0.7%
Enterprise value$608.9M

Returns & leverage

See full
Return on equity-34.3%
Debt / equity
Current ratio38×

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Schering-Plough’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:30 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001778922-26-000035
Line itemAs of / March 31, 2026As of / December 31, 2025
Other receivables653431
Prepaid expenses and other current assets1,707901
Total current assets253,362108,768
Other non-current assets789492
Property and equipment, net2,7452,339
Deferred offering costs2,715
Right-of-use asset1,4901,552
Total assets$258,386$115,866

Item 1F. Financial Statements (Unaudited) Item 1. Financial Statements

FAQ

What is Schering-Plough's deferred tax assets and other non-current assets?
Schering-Plough (SGP) reported deferred tax assets and other non-current assets of $789K in Q1 2026.

Ask your AI about Schering-Plough's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude